On Wednesday, biotech managed a small rise, while the broad market was up sharply. The Centient Biotech 200™ gained 2.90 points, an .08% move. Meanwhile, the NYSE Composite gained .78%, while Nasdaq did even better, making a 1% rise. Although the Biotech 200 didn’t move very far, some individual stocks did. We take a look at CV Therapeutics, Abgenix, ID Biomedical, and Genitope.
